|
|
 |
|
Viewing report
|
|
|
|
Rib-X Pharmaceuticals, Inc. - Strategic SWOT Analysis Review
GlobalData, Aug 2011, Pages: 25
Rib-X Pharmaceuticals, Inc. - Strategic SWOT Analysis Review
Summary
Rib-X Pharmaceuticals, Inc. (Rib-X) is a privately owned drug discovery and development company. It engages in the research and development of small molecule anti-infective agents. The company’s underlying drug discovery system depends on its proprietary high-resolution crystal structure of the ribosome, which performs an essential role in the fundamental process of protein synthesis. Its combined research strategy which integrates state of the art, proprietary computational analysis, X-ray crystallography, medicinal chemistry, microbiology and biochemistry, allows the company to rapidly synthesize new agents to prevent typical antibiotic resistance mechanisms. Rib-X technology has a competitive edge on many antibiotics which function by inhibiting the process of the ribosome. The product pipeline of the company includes Delafloxacin, Radezolid, Rx-02 and Rx-04. Rib-X is headquartered at New Haven in Connecticut, the US.
Rib-X Pharmaceuticals, Inc. Key Recent Developments…
Jul 06, 2011: Sanofi And Rib-X Pharma Sign Research Collaboration Agreement On New Classes Of Antibiotics
Jun 15, 2011: Rib-X Pharmaceuticals Supports Generating Antibiotic Incentives Now Act
Mar 23, 2010: Rib-X Appoints Mark Leuchtenberger As President And CEO
Feb 16, 2010: Yale University And Rib-x Announce Discovery Of Ribosome Antibiotic Structures
Jan 20, 2010: Rib-X Names Peter Greenleaf As New Board Member
GlobalData’s Rib-X Pharmaceuticals, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
Note: Some sections may be missing if data is unavailable for the company.
Reasons to Buy
- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
|
|
|
|
